Markus S.
- Country
- Austria
- Department
- Department of Pediatric Hematology/Oncology
Research Overview
Data & Insights
Has run more than one trial at 0 of 77 partner sites.
Specializations
Pediatric Oncology
The investigator specializes in the treatment of Langerhans Cell Histiocytosis (LCH) in children and adolescents, with particular focus on innovative therapeutic approaches for this rare histiocytic disorder.
- Multi-system LCH management
- Risk organ involvement assessment
- Early intervention strategies
Their work encompasses comprehensive treatment protocols for varying manifestations of LCH, from single-system to multi-system involvement.
Treatment Optimization
The investigator focuses on developing optimal therapeutic strategies for CNS-Risk lesions and multifocal bone involvement in pediatric patients. Their expertise extends to evaluating continuation therapy durations and intensification protocols.
- Salvage treatment protocols
- Continuation therapy optimization
- Reactivation prevention
Their approach includes investigating various therapeutic combinations to enhance treatment outcomes.
Long-term Outcomes
The investigator's work centers on preventing disease progression and improving long-term outcomes in histiocytic disorders. Their research examines strategies to reduce late sequelae and disease reactivation.
- Sequential therapy approaches
- Disease resolution monitoring
- Late complications prevention
Their research encompasses both conventional and innovative therapeutic combinations for sustained disease control.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.